Bartlett & Co. LLC’s Novartis AG Position
Does Bartlett & Co. LLC own Novartis AG (NVS)? Yes — 151.0K shares worth $15M (+0.25% of its 13F portfolio) as of Q4 2023, down from 153.0K shares the prior filed quarter.
Position Value
$15M
Q4 2023
Shares
151.0K
% of Portfolio
+0.25%
Quarters Held
18
currently held
Position History NVS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 151.0K | $15M | +0.25% |
| Q3 2023 | 153.0K | $16M | +0.28% |
| Q2 2023 | 155.8K | $16M | +0.27% |
| Q1 2023 | 167.6K | $15M | +0.30% |
| Q4 2022 | 177.9K | $16M | +0.32% |
| Q3 2022 | 181.3K | $14M | +0.30% |
| Q2 2022 | 184.1K | $16M | +0.32% |
| Q1 2022 | 215.4K | $19M | +0.33% |
| Q3 2021 | 220.9K | $18M | +0.34% |
| Q2 2021 | 222.0K | $20M | +0.39% |
| Q1 2021 | 229.9K | $20M | +0.40% |
| Q4 2020 | 236.7K | $22M | +0.48% |
| Q3 2020 | 240.8K | $21M | +0.49% |
| Q2 2020 | 234.6K | $20M | +0.54% |
| Q1 2020 | 237.7K | $20M | +0.60% |
| Q3 2019 | 247.5K | $22M | +0.56% |
| Q2 2019 | 257.3K | $23M | +0.88% |
| Q1 2019 | 448.2K | $43M | +1.65% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bartlett & Co. LLC’s full portfolio or all institutional holders of NVS.